Building Flesh and Blood

Understanding how networks of blood vessels form is key to engineering transplantable organs and tissues.

Written byJalees Rehman
| 12 min read

Register for free to listen to this article
Listen with Speechify
0:00
12:00
Share

LIFELINES: The arteries and veins of the human heart (shown here injected with dyed gelatin) are critical to the organ’s function, with blood flow delivering life-giving nutrients to the cardiac muscles while removing toxic waste. In the quest to engineer transplantable organs, researchers must consider how to build comparable blood-vessel networks. © SPL/SCIENCE SOURCE

Thousands of unfortunate patients are badly in need of a replacement organ. As of April 2014, more than 122,000 such people in the United States were on the waiting list maintained by the national Organ Procurement and Transplant Network. But fewer than 30,000 of those patients will actually receive the transplant surgery they need this year. That’s because living or deceased donors constitute the only source of new organs, one that for years has not been able to keep pace with demand.

As the number of patients with severe, irreversible organ damage continues to rise, this gap will only widen. To fill the need, researchers are exploring whether they can build functional organs from scratch. Since the 1980s and 1990s, scientists and surgeons have used ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies